Latest press releases

 

 

ADDvise receives allocation decision worth approximately EUR 5 million

Regulatory press release

ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from Oulu University Hospital in Finland regarding a long-term partnership for delivery of x-ray equipment and services during a ten-years period, with a total value of EUR 5 million. First installations are expected to take place during the year 2023. In accordance with…

Read more

ADDvise acquires Southern Life Systems, Inc.

Regulatory press release

ADDvise Group AB has today entered into a share purchase agreement with the owners of Sothern Life Systems, Inc. (“SLS”) regarding the acquisition of all shares of SLS in accordance with the letter of intent communicated via a press release dated August 30, 2021. Closing of the acquisition takes place today. SLS’ revenue for the…

Read more

ADDvise Group appoints interim CFO

Regulatory press release

ADDvise Group AB appoints Bengt Miller as interim Chief Financial Officer (CFO) and temporary member of the management team. He succeeds the current CFO, Aaron Wong, and will assume the role on 29 November 2021 until the 28[th] of February 2022 when the newly appointed CFO, Sebastian Robson, as previously communicated, commences his employment. Bengt…

Read more

ADDvise receives order worth USD 530,000

Regulatory press release

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Masarat in Saudi Arabia, a company providing biosafety- and cleanroom services. The order is worth approximately USD 530,000 and involves design and construction of a cleanroom facility for the manufacturing of surgical sutures for Advanced Bio-Medical Industrial Co in Saudi Arabia. Delivery of…

Read more

ADDvise receives order worth USD 800,000

Regulatory press release

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Masarat in Saudi Arabia, a company providing biosafety- and cleanroom services. The order is worth approximately USD 800,000 and involves design and construction of cleanroom facilities for controlled biosafety laboratories for IAU University in Saudi Arabia. Delivery of the order is planned to…

Read more

ADDvise receives order worth USD 1.8 million

Regulatory press release

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Cordeel, a multinational construction company. The order is worth approximately USD 1.8 million and involves construction of cleanrooms for a pharmaceutical production facility in Bulgaria for TEVA Pharmaceutical. Delivery of the order is planned to take place during Q3 2022. – The market…

Read more

ADDvise Group successfully issues subsequent senior secured bonds of 250 MSEK

Regulatory press release

ADDvise Group AB (publ) ("ADDvise" or the "Company") announces today that the Company has successfully placed a subsequent senior secured bond issue (the “Subsequent Bond Issue) in an amount of 250 MSEK under the Company’s existing senior secured bond framework with ISIN SE0015222088. Following the Subsequent Bond Issue, the outstanding amount under the senior secured…

Read more

ADDvise Group investigates the possibility to issue subsequent senior secured bonds

Regulatory press release

ADDvise Group AB (publ) has mandated Pareto Securities AB to arrange a series of fixed income investor meetings and, subject to inter alia market conditions, a subsequent bond issue under the company’s existing senior secured bond framework with ISIN SE0015222088 may follow. The net proceeds from the potential subsequent bond issue will be used to…

Read more

Interim report 2021, January 1 – September 30

Regulatory press release

July – September 2021 Net revenue for the period was SEK 105.6 million (76.2), an increase of 38.6 %. Organic growth was 12.1 %. Adjusted EBITDA for the period was SEK 14.5 million (5.3) EBITDA for the period was SEK 13.3 million (9.4) Adjusted profit/loss for the period was SEK 3.0 million (-1.2) Basic earnings…

Read more

ADDvise Group appoints new CFO

Regulatory press release

ADDvise Group AB (publ) appoints Sebastian Robson as new Chief Financial Officer (CFO) and member of the executive management team. He succeeds the current CFO, Aaron Wong, and will commence his employment no later than 28 February 2022. Sebastian’s most recent position is as CFO of Hexicon AB (publ), listed on Nasdaq First North. Sebastian…

Read more

ADDvise signs Letter of Intent to acquire Poly Pharmaceuticals, Inc.

Regulatory press release

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Poly Pharmaceuticals, Inc. (”Poly Pharma”) regarding an acquisition of 100 percent of the shares in Poly Pharma. Poly Pharma is an American pharmaceutical company specializing in the development, production and marketing of over-the-counter generic pharmaceuticals for treatment of coughs, colds, allergies,…

Read more

ADDvise Group’s nomination committee for the Annual General Meeting 2022

Regulatory press release

In accordance with the resolution at the 2021 annual general meeting of ADDvise Group AB, the nomination committee for the annual general meeting 2022 shall be composed of representatives of the three largest shareholders by votes listed in the shareholders’ register, which is maintained by Euroclear Sweden as of 30 June 2021, and the chairman…

Read more

ADDvise Group’s reporting dates 2022

Regulatory press release

Year-End Report 2021 (Jan-Dec)                                 2022-02-24 Last day for shareholders to request                            2022-03-18 an item to be included to the agenda of the Annual General Meeting Interim Report (Jan-March 2022)                       …

Read more

On account of the difference in price movements in ADDvise Group’s shares

Regulatory press release

ADDvise Group AB (publ) (“ADDvise” and the “Company”) notes positive price movements in the Company's shares. ADDvise's share of series A carries one vote and share of series B carries one tenth of a vote, and besides this difference, the Company is not aware of any information concerning the Company which explains the difference between…

Read more

ADDvise updates long-term financial goals

Regulatory press release

ADDvise Group AB raises its long-term EBITDA financial target from 15% to 20%. ADDvise also raises its long-term revenue growth target from 20% to 25%. Other long-term financial goals remain unchanged. For the financial year 2022, on a pro forma basis rolling 12 months, ADDvise expects to reach revenue of SEK 1 billion with an…

Read more

ADDvise acquires Graham Medical Technologies, LLC

Regulatory press release

ADDvise Group AB has today entered into a share purchase agreement with the owner of Graham Medical Technologies, LLC (“GraMedica”) regarding the acquisition of all the outstanding shares of GraMedica in accordance with the letter of intent communicated via a press release dated 10[th] May 2021. Closing of the acquisition takes place today. GraMedica’s revenue…

Read more

ADDvise Group completes a directed new share issue of approximately SEK 125 million which was multiple times oversubscribed

Regulatory press release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER…

Read more

ADDvise Group announces intention to carry out a directed new share issue of approximately SEK 125 million

Regulatory press release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER…

Read more

ADDvise signs Letter of Intent to acquire Southern Life Systems, Inc.

Regulatory press release

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Southern Life Systems, Inc. (”SLS”) regarding an acquisition of 100 percent of the shares in SLS. SLS is an American medtech company that is market leading in providing equipment and software for monitoring patients in long-term care. SLS has developed the…

Read more

ADDvise strengthens the management team, recruits COO

Regulatory press release

ADDvise strengthens its Group management and recruits Fredrik Mella as COO. Fredrik has extensive international experience in the Medtech industry and has held key positions such as CEO, sales manager, COO and board member.

Read more

ADDvise completes the acquisition of Medisuite, LLC

Regulatory press release

ADDvise Group AB (publ) has today completed the acquisition of all shares in Medisuite, LLC in accordance with the share purchase agreement as previously communicated via a press release on 30 July 2021. Medisuite will be consolidated into ADDvise’s financial reporting as of August 2021. The local management of Medisuite and its operational business structure…

Read more

ADDvise acquires Medisuite, LLC

Regulatory press release

ADDvise Group AB has today entered into a share purchase agreement with the owner of Medisuite LLC regarding the acquisition of all the outstanding shares of Medisuite, LLC in accordance with the letter of intent communicated via a press release dated 24[th] May 2021. Closing of the acquisition is expected to take place in August…

Read more

ADDvise Group’s CFO Aaron Wong resigns

Regulatory press release

Aaron Wong, CFO and member of the management team of ADDvise Group AB (publ) since October 2018, has today announced that he will step down from his position as Chief Financial Officer to focus on his family and to pursue other opportunities. Aaron will remain as CFO until 28[th] January 2022, and the process of…

Read more

Interim report 2021, January 1 – June 30

Regulatory press release

April – June 2021 Net revenue for the period was SEK 117.6 million (101.8) EBITDA for the period was SEK 15.8 million (15.1) EBITA for the period was SEK 13.3 million (13.1) Profit/loss for the period was SEK 0.1 million (8.3) Basic earnings per share for the period amounted to SEK 0.00 (0.07) Orders received…

Read more

ADDvise completes the acquisition of MRC Systems FZE

Regulatory press release

ADDvise Group AB (publ) (”ADDvise”) has today completed the acquisition of all shares in MRC Systems FZE (”MRC”). The signing of the share purchase agreement has been communicated to the market via a press release on 16 February 2021. The total purchase price amounts to USD 8.00 million, of which USD 4.50 million has been…

Read more

ADDvise Group AB (publ) to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds with ISIN SE0010298166

Regulatory press release

We refer to the outstanding up to SEK 240,000,000 senior secured callable bonds issued by ADDvise Group AB (publ) (the "Company") with ISIN: SE0010298166 (the "Bonds") and to the terms and conditions of the Bonds (the "Terms and Conditions"). Reference is further made to a call notice dated 21 May 2021, in which the Company…

Read more

ADDvise signs Letter of Intent to acquire Medisuite, LLC

Regulatory press release

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Medisuite, LLC (”Medisuite”) regarding an acquisition of 100 percent of the shares in Medisuite. Medisuite is an American online pharmacy that specializes in medication for men’s health. The prescription medication that is marketed by Medisuite is mainly used for treatment of…

Read more

ADDvise Group to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds

Regulatory press release

ADDvise Group AB (publ) (“ADDvise") hereby announces that ADDvise’s up to SEK 240,000,000 senior unsecured callable floating rate bonds with ISIN SE0010298166 (the "Bonds"), will be redeemed in advance in accordance with Clause 8.3 (Voluntary total redemption (call option)) of the terms and conditions of the Bonds. The redemption date will be 18 June 2021.…

Read more

ADDvise Group issues a senior secured bond loan of 250 MSEK

Regulatory press release

ADDvise Group AB (publ) ("ADDvise" or the "Company") announces today that the Company has successfully placed a senior secured bond loan with an initial volume of 250 MSEK within a framework of 500 MSEK. The bond has a tenor of three years and carries interest at an annual rate of 3 months STIBOR plus 725…

Read more

ADDvise Group investigates the possibility to issue secured bonds

Regulatory press release

ADDvise Group AB (publ) ("ADDvise" or the "Company") has mandated Pareto Securities AB to investigate the possibility of a senior secured bond issue with an expected volume of SEK 250,000,000 and a tenor of three years. The proceeds from the potential bond issue will be used to repay the Company's outstanding bonds and other credit…

Read more

ADDvise received order worth SEK 9 million

Regulatory press release

ADDvise Group AB’s subsidiary Labrum AB has received an order from Takura AB, a company specialized in clinical phase cell therapy, worth approximately SEK 9 million. The order involves construction of a cleanroom including laboratory equipment to the production facility for cell therapy that Takura AB is going to build, through its subsidiary CellCo and…

Read more

ADDvise signs Letter of Intent to acquire Graham Medical Technologies, L.L.C.

Regulatory press release

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholder of Graham Medical Technologies, L.L.C. (“GraMedica”) regarding an acquisition of 100 percent of the shares in GraMedica. GraMedica is specialized in the development of orthopedic implants and stents for feet and ankle surgery. GraMedica was founded in 2003, and since, the company…

Read more

Interim report 2021, January 1 – March 31

Regulatory press release

January – March 2021 Net revenue for the period was SEK 87.7 million (83.7) EBITDA for the period was SEK 8.9 million (5.4) EBITA for the period was SEK 6.9 million (3.4) Profit/loss for the period was SEK 2.5 million (-2.5) Basic earnings per share for the period amounted to SEK 0.02 (-0.02) Orders received…

Read more

ADDvise Group AB (publ) publishes the 2020 annual report – Regulatory information

Regulatory press release

Today, on 31 March 2021, ADDvise Group AB (publ) is publishing its annual report for 2020. The annual report is available on ADDvise’s website: www.addvisegroup.se. The annual report is published in Swedish and English. The Swedish version represents the original.   For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se Important information:…

Read more

The nomination committee’s proposal of board of directors in ADDvise Group AB (publ) – Regulatory information

Regulatory press release

To the annual general Meeting (AGM) of ADDvise Group AB (publ) on 23 April 2021, the nomination committee has decided to propose the re-election of the current board members Rikard Akhtarzand, Fredrik Celsing, Staffan Torstensson and Erland Pontusson as members of the board of directors. In addition, the nomination committee proposes the election of Johanne…

Read more

ADDvise Group acquires MRC Systems FZE – Regulatory information

Regulatory press release

ADDvise Group AB (publ) ("ADDvise") has entered into a share purchase agreement with the shareholders of MRC Systems FZE (the "Company" and "MRC") regarding an acquisition of 100 percent of the shares in the Company (the "Acquisition"). MRC develops and manufactures cleanrooms for the pharmaceutical industry and hospitals. The Company has its headquarters and production…

Read more

ADDvise Group AB receives SEK 27.8 million through the warrants of series 2019/2021 – Regulatory information

Regulatory press release

Holders of warrants of series 2019/2021 subscribed for 42,787,137 warrants, corresponding to 99.41 percent of the outstanding warrants, for subscription of 42,787,137 shares of series B at the subscribtion price of SEK 0.65. Through the exercise of the warrants, ADDvise receives SEK 27,811,639 before issue costs. Background During the first quarter of 2019, ADDvise carried…

Read more

Result update Q4, full year 2020 and the board of directors’ dividend proposal – Regulatory information

Regulatory press release

Preliminary numbers indicate very strong growth for ADDvise Group during the fourth quarter for 2020, which will be substantially better than last year. ADDvise Group considers this to be above market expectations. With a more normalized market, an increase of ADDvise’s own products and margins, and a continued control of costs; EBITDA has increased as…

Read more

Certain Board members, senior executives and major shareholders have undertaken to subscribe for shares for a total of approx. SEK 15.5 million by exercising warrants of series 2019/2021

Regulatory press release

The following board members, senior executives and major shareholders in ADDvise Group AB (publ) (“ADDvise”) have irrevocably undertaken to exercise a total of 23,813,195 warrants of series 2019/2021, which corresponds to a total of approximately 55% of the warrants of series 2019 / 2021 (“The Warrants”). The subscription means that ADDvise will receive issue proceeds…

Read more